ResApp Quarterly Report – Q2 2015

Successful Capital Raise and Commencement of Trading Key Clinical Study Progressing Well Highlights Successful, oversubscribed $4 million capital raise Funds raised to accelerate the commercialisation of its mobile applications for the diagnosis and management of...

ResApp Appoints New Chairman, Dr Roger Aston

ResApp Health Limited (ASX: RAP) is pleased to announce the appointment of Dr Roger Aston as Non-Executive Chairman of the company. Dr Aston replaces Mr Adam Sierakowski who remains on the board as a Non-Executive Director. Dr Aston is both a scientist and a seasoned...